United States · FDA National Drug Code directory
Sertraline Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-435_730d7b7d-3846-47b2-b527-c2bb233f8052
- Product NDC
- 71610-435
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sertraline Hydrochloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070206
- Source listing expiry
- 20261231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 45 TABLET, FILM COATED in 1 BOTTLE (71610-435-45) · 71610-435-45
- 60 TABLET, FILM COATED in 1 BOTTLE (71610-435-53) · 71610-435-53
- 90 TABLET, FILM COATED in 1 BOTTLE (71610-435-60) · 71610-435-60
- 135 TABLET, FILM COATED in 1 BOTTLE (71610-435-73) · 71610-435-73
- 180 TABLET, FILM COATED in 1 BOTTLE (71610-435-80) · 71610-435-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →